The largest database of trusted experimental protocols

4 protocols using c 12909

1

Differentiation of Human Monocytes into Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monocytes, isolated from blood as well as commercial monocytes i.e. CD14 + Monocytes from Peripheral blood, single donor (PromoCell, C-12909), were utilized. After thawing, the cells were cultured in a 25 cm2 culture bottle in monocyte-to-macrophage medium (Table 1) to differentiate the monocytes towards macrophages. Human serum in the medium differentiates monocytes into macrophages (Andreesen et al. 1983 (link); Musson 1983 (link)). For the first 24 h after thawing, the cells were allowed to recover. Then fresh medium was changed. After 3 days, some of monocytes had attached to the bottom and differentiated to macrophages, whereas some of monocytes were growing in suspension. Every 4–5 days, half of the medium was changed, and the morphology of the cells was monitored by microscope. After 10 days, cells growing were subcultured with ratio of 1:2 into 25 cm2 culture bottles. After culturing the cells for 24 days, the macrophages were differentiated and ready to be used in the construction of the in vitro models. Maturity was tested with methods presented in paragraph “Analysis of isolated and differentiated macrophages”. Detachment of macrophages was done by Macrophage detachment solution DXF (PromoCell, C-41330) and scraping with a cell scraper.
+ Open protocol
+ Expand
2

THP-1 Cell Cultivation and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultivation and siRNA treatment of THP1 cells (DSMZ GmbH, Braunschweig, Germany) was performed as previously reported [7 (link)]. Briefly, the cell line was authenticated via MLL-AF9 breakpoint sequencing, was routinely checked for mycoplasma contamination and transfected with 50 nM Silencer Select siRNAs (Life Technologies, Carlsbad, CA, USA) and Dreamfect (OZ Biosciences, Marseille, France) leading to transfection efficiencies and survival rates of 93 % each. Experimental incubations lasted eight days with repeated transfections on day 0, 3, and 6. Prior to each transfection event, cell densities were determined and cells were reseeded at 5 × 104 cells per ml [7 (link)].
THP1 miRNA mimic transfections were performed as described for siRNA transfections but with 30 nM Ambion Pre-miR miRNA Precursors (hsa-miR-511-5p AM10237, neg Control #1 AM17110, neg Control #2 AM17111) and experimental incubations up to day nine again with repeated transfections on day 0, 3, and 6.
Human CD14+ monocytes (C-12909, PromoCell GmbH, Heidelberg, Germany) were cultivated for 48 h in mononuclear cell medium (PromoCell) prior to immunostaining and RNA isolation. Human CD34+ progenitor cells (C-12921, PromoCell) were directly taken to RNA isolation.
+ Open protocol
+ Expand
3

Macrophage Polarization with IL-4

Check if the same lab product or an alternative is used in the 5 most similar protocols
A human macrophage cell line (human CD14+ monocytes from peripheral blood, single donor; C-12909, http://www.promocell.com/product/human-cd14-monocytes-hmocd14-pb/) from PromoCell GmbH (Heidelberg, Germany) was cultured at a density of 1×106 cells in Monocyte Attachment Medium (PromoCell GmbH). Cells were cultured in M1-Macrophage Generation Medium DXF so that they could differentiate into M1- and M2-like macrophages as in our previous study (19 (link)). In addition, these cells were treated with 1, 10 or 20 ng/ml of interleukin-4 (IL-4; R&D Systems) for 24 h. Human monocytic (THP-1) cells were obtained from the American Type Culture Collection and maintained in RPMI-1640 containing 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.), 1% penicillin-streptomycin (Gibco; Thermo Fisher Scientific, Inc.), and 2 mmol/l of glutamine (Gibco; Thermo Fisher Scientific, Inc.).
+ Open protocol
+ Expand
4

Cytokine-Induced Macrophage CCL22 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CCL22 protein expression via IL-4 (R&D Systems), with or without AS1517499 (Axon Medchem BV) as a selective STAT6 inhibitor, in human macrophage cell line (C-12909; PromoCell GmbH) culture supernatants was measured using an enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems) as in a previous study (29 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!